Phase II SBRT & Chemo for Unresectable Cholangiocarcinoma Followed by Liver Transplantation
Status:
Terminated
Trial end date:
2012-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine progression-free survival at 12 months for
stereotactic body radiotherapy (SBRT) and chemotherapy for unresectable hilar
cholangiocarcinoma (CCA).